• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织工程和干细胞治疗在神经原性膀胱功能障碍中的应用:现状与未来展望。

Tissue Engineering and Stem Cell Therapy in Neurogenic Bladder Dysfunction: Current and Future Perspectives.

机构信息

National Institute of Rheumatic Diseases, Nabrezie I. Krasku 4, 921 12 Piestany, Slovakia.

Department of Urology, Faculty of Medicine, Comenius University in Bratislava, Limbova 5, 833 05 Bratislava, Slovakia.

出版信息

Medicina (Kaunas). 2023 Aug 3;59(8):1416. doi: 10.3390/medicina59081416.

DOI:10.3390/medicina59081416
PMID:37629705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10456466/
Abstract

Tissue engineering (TE) is a rapidly evolving biomedical discipline that can play an important role in treating neurogenic bladder dysfunction and compensating for current conventional options' shortcomings. This review aims to analyze the current status of preclinical and clinical trials and discuss what could be expected in the future based on the current state of the art. Although most preclinical studies provide promising results on the effectiveness of TE and stem cell therapies, the main limitations are mainly the very slow translation of preclinical trials to clinical trials, lack of quality research on neurogenic preconditions of neurogenic bladder dysfunction outside of the spinal cord injury and varying therapeutic methods of the existing research that lacks a standardized approach.

摘要

组织工程(TE)是一个快速发展的生物医学学科,可以在治疗神经源性膀胱功能障碍和弥补当前常规治疗方法的不足方面发挥重要作用。本综述旨在分析当前的临床前和临床试验现状,并根据现有技术水平讨论未来可能的发展方向。尽管大多数临床前研究提供了关于 TE 和干细胞治疗有效性的有希望的结果,但主要的局限性主要是临床前试验向临床试验的转化非常缓慢,缺乏对脊髓损伤以外的神经源性膀胱功能障碍的神经源性前提的高质量研究,以及现有的治疗方法缺乏标准化方法,治疗方法各不相同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37e2/10456466/264ca50806a3/medicina-59-01416-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37e2/10456466/264ca50806a3/medicina-59-01416-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37e2/10456466/264ca50806a3/medicina-59-01416-g001.jpg

相似文献

1
Tissue Engineering and Stem Cell Therapy in Neurogenic Bladder Dysfunction: Current and Future Perspectives.组织工程和干细胞治疗在神经原性膀胱功能障碍中的应用:现状与未来展望。
Medicina (Kaunas). 2023 Aug 3;59(8):1416. doi: 10.3390/medicina59081416.
2
Stem Cell Therapy in Spinal Cord Injury-Induced Neurogenic Lower Urinary Tract Dysfunction.脊髓损伤所致神经源性下尿路功能障碍的干细胞治疗
Stem Cell Rev Rep. 2023 Aug;19(6):1691-1708. doi: 10.1007/s12015-023-10547-9. Epub 2023 Apr 28.
3
[Survey of acupuncture treatment for neurogenic bladder dysfunction after spinal cord injuries].[脊髓损伤后神经源性膀胱功能障碍的针刺治疗调查]
Zhongguo Zhen Jiu. 2008 Oct;28(10):779-82.
4
Oral mucosa stem cells alleviates spinal cord injury-induced neurogenic bladder symptoms in rats.口腔黏膜干细胞可缓解大鼠脊髓损伤诱导的神经源性膀胱症状。
J Biomed Sci. 2014 May 13;21(1):43. doi: 10.1186/1423-0127-21-43.
5
The Role of Health Insurance in Patient Reported Satisfaction with Bladder Management in Neurogenic Lower Urinary Tract Dysfunction Due to Spinal Cord Injury.健康保险在脊髓损伤导致的神经源性下尿路功能障碍患者对膀胱管理的满意度报告中的作用。
J Urol. 2021 Jan;205(1):213-218. doi: 10.1097/JU.0000000000001346. Epub 2020 Aug 28.
6
Editorial: use of neuronal stem cells to treat neurogenic bladder due to spinal cord injury.社论:使用神经干细胞治疗脊髓损伤所致神经源性膀胱
J Urol. 2003 Oct;170(4 Pt 1):1426. doi: 10.1097/01.ju.0000086041.87264.04.
7
Non-traditional management of the neurogenic bladder: tissue engineering and neuromodulation.神经源性膀胱的非传统管理:组织工程与神经调节
ScientificWorldJournal. 2007 Aug 17;7:1230-41. doi: 10.1100/tsw.2007.178.
8
The management of neurogenic bladder and sexual dysfunction after spinal cord injury.脊髓损伤后神经源性膀胱和性功能障碍的管理
Spine (Phila Pa 1976). 2001 Dec 15;26(24 Suppl):S129-36. doi: 10.1097/00007632-200112151-00022.
9
Towards a catheter free status in neurogenic bladder dysfunction: a review of bladder management options in spinal cord injury (SCI).迈向神经源性膀胱功能障碍的无导管状态:脊髓损伤(SCI)膀胱管理方案综述
Spinal Cord. 2001 Jul;39(7):355-61. doi: 10.1038/sj.sc.3101132.
10
A systematic review and comparison of questionnaires in the management of spinal cord injury, multiple sclerosis and the neurogenic bladder.脊髓损伤、多发性硬化症和神经源性膀胱管理中问卷的系统评价与比较
Neurourol Urodyn. 2016 Mar;35(3):354-64. doi: 10.1002/nau.22720. Epub 2015 Jan 25.

引用本文的文献

1
Enhanced Bladder Regeneration with Adipose-Derived Stem Cell-Seeded Silk Fibroin Scaffolds: A Comparative Analysis.脂肪来源干细胞接种的丝素蛋白支架促进膀胱再生:一项对比分析。
Biomimetics (Basel). 2025 Feb 7;10(2):93. doi: 10.3390/biomimetics10020093.
2
Adipose-Derived Stem Cells: Angiogenetic Potential and Utility in Tissue Engineering.脂肪来源干细胞:血管生成潜能及其在组织工程中的应用。
Int J Mol Sci. 2024 Feb 16;25(4):2356. doi: 10.3390/ijms25042356.
3
Editorial: From single stem cells to organoids, organ repair, and public health Volume II.

本文引用的文献

1
Differentiation of patient-specific void urine-derived human induced pluripotent stem cells to fibroblasts and skeletal muscle myocytes.将患者特定的尿液来源的人诱导多能干细胞分化为成纤维细胞和骨骼肌肌细胞。
Sci Rep. 2023 Mar 23;13(1):4746. doi: 10.1038/s41598-023-31780-9.
2
Tissue engineering in reconstructive urology-The current status and critical insights to set future directions-critical review.重建泌尿外科中的组织工程——当前现状及对设定未来方向的关键见解——批判性综述
Front Bioeng Biotechnol. 2023 Mar 1;10:1040987. doi: 10.3389/fbioe.2022.1040987. eCollection 2022.
3
Ethical and regulatory issues of stem cell-derived 3-dimensional organoid and tissue therapy for personalised regenerative medicine.
社论:从单一干细胞到类器官、器官修复与公共卫生 第二卷
Front Cell Dev Biol. 2023 Sep 25;11:1294407. doi: 10.3389/fcell.2023.1294407. eCollection 2023.
干细胞衍生的三维类器官和组织治疗在个体化再生医学中的伦理和监管问题。
BMC Med. 2022 Dec 27;20(1):499. doi: 10.1186/s12916-022-02710-9.
4
Adverse events, side effects and complications in mesenchymal stromal cell-based therapies.基于间充质基质细胞的疗法中的不良事件、副作用和并发症。
Stem Cell Investig. 2022 Nov 8;9:7. doi: 10.21037/sci-2022-025. eCollection 2022.
5
Implantation of adipose-derived mesenchymal stem cell sheets promotes axonal regeneration and restores bladder function after spinal cord injury.脂肪间充质干细胞片的植入促进了脊髓损伤后的轴突再生和膀胱功能的恢复。
Stem Cell Res Ther. 2022 Oct 12;13(1):503. doi: 10.1186/s13287-022-03188-1.
6
Application of 3D Bioprinting in Urology.3D生物打印在泌尿外科中的应用。
Micromachines (Basel). 2022 Jul 7;13(7):1073. doi: 10.3390/mi13071073.
7
Tissue Engineering and Regenerative Medicine in Pediatric Urology: Urethral and Urinary Bladder Reconstruction.小儿泌尿外科学中的组织工程和再生医学:尿道和膀胱重建。
Int J Mol Sci. 2022 Jun 7;23(12):6360. doi: 10.3390/ijms23126360.
8
Application of antibody-conjugated small intestine submucosa to capture urine-derived stem cells for bladder repair in a rabbit model.抗体偶联小肠黏膜下层在兔模型中应用于捕获尿源干细胞以修复膀胱
Bioact Mater. 2021 Nov 27;14:443-455. doi: 10.1016/j.bioactmat.2021.11.017. eCollection 2022 Aug.
9
Human umbilical cord mesenchymal stem cells contribute to the reconstruction of bladder function after acute spinal cord injury via p38 mitogen-activated protein kinase/nuclear factor-kappa B pathway.人脐带间充质干细胞通过 p38 丝裂原活化蛋白激酶/核因子-κB 通路促进急性脊髓损伤后膀胱功能的重建。
Bioengineered. 2022 Mar;13(3):4844-4856. doi: 10.1080/21655979.2022.2036397.
10
Non-human primate pluripotent stem cells for the preclinical testing of regenerative therapies.用于再生疗法临床前测试的非人灵长类多能干细胞。
Neural Regen Res. 2022 Sep;17(9):1867-1874. doi: 10.4103/1673-5374.335689.